BRIEF-Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

Reuters
24 Apr
BRIEF-Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

April 24 (Reuters) - Guardant Health Inc GH.O:

  • GUARDANT HEALTH ANNOUNCES STRATEGIC COLLABORATION WITH PFIZER TO SUPPORT DEVELOPMENT AND COMMERCIALIZATION OF NEW CANCER THERAPIES USING GUARDANT INFINITY SMART LIQUID BIOPSY PLATFORM

  • GUARDANT HEALTH INC - COLLABORATION PROVIDES PFIZER ACCESS TO GUARDANT TESTS IN CHINA

Source text: ID:nBw3L8GL7a

Further company coverage: GH.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10